InvestorsHub Logo

powerbattles

03/16/24 2:45 AM

#4512 RE: DD_dempsey #4510

It's astonishing how some people react to news in the market these days. It's the usual behavior of Ihub grasshoppers, but that's fine. People come and go constantly. I anticipate that only a select few individuals with a clear vision, capable of seeing the bigger picture, will remain here in the end.

The company released some incredible news. It seems to be more of an update, packed with highly valuable information, and some individuals didn't grasp it on their initial read-through. Honestly, I had to read it a few times to fully understand the important messages they aim to convey. The quote below is particularly challenging to digest due to its abundance of details condensed into a very brief sentence.

We foresee significant growth once we open DTC and OTC markets with FDA approval, which we will apply for, for skin care and hair growth products using human exosomes. We currently have a professional sales force with 700+ independent sales reps and distribution partners covering all aspects of our brand ecosystem. The company's subsidiaries will benefit from synergies in all backroom disciplines as well as sales & marketing and a seasoned collaborative management team.


We're just getting started, and we're already making significant strides. Having over 700 independent sales reps indicates a significant workforce and a substantial team. Moreover, the question arises: who is our distribution partner? If our distribution partner happens to be Walmart, Walgreens, CVS, or any major pharmacy store chain in the United States, it would be highly beneficial for the stakeholders involved.

Pay attention to their statement quote above, they anticipate a substantial increase in business once they sell their products directly to consumers (DTC - Direct to Consumer) and through over-the-counter (OTC) channels, after receiving approval from the Food and Drug Administration (FDA).

FDA Approval: They likely expect increased demand for their skincare and hair growth products once they can reach consumers more easily and with the endorsement of FDA approval.

FDA approval is a regulatory process by which the Food and Drug Administration evaluates the safety and effectiveness of new products, including skincare and hair growth products. Getting FDA approval is crucial for ensuring that the products meet certain standards of safety and efficacy.

This is where the excitement kicks in, something that many haven't quite grasped yet.
Human Exosomes: Exosomes are tiny vesicles that contain various molecules, such as proteins and nucleic acids, which are released by cells. Using human exosomes in skincare and hair growth products suggests that the company is employing advanced biotechnology in their formulations, which they believe will be attractive to consumers and potentially more effective than traditional products.

To uncover the wonders of advanced biotechnology, you need to tune in to the company's CINEMA advertising campaigns.
https://apollobiowellness.com/on-demand-content/
Bullish
Bullish

SecondLife

03/17/24 9:27 PM

#4537 RE: DD_dempsey #4510

Great read… thank you for your expertise. Very much appreciated. Have yourself a good one.
Bullish
Bullish